Back
argenx SE Vs. Biodexa Pharmaceuticals PLC Industry Stock Comparison
Buy
62
ARGX
argenx SE
Last Price:
606.26
Seasonality Move:
44.25%
Sell
20
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
4.79
Seasonality Move:
-24.92%
Buy
62
argenx SE (ARGX)
is a Buy
Is argenx SE a Buy, Sell or Hold?
- The current argenx SE [ARGX] share price is $596.74. The Score for ARGX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- ARGX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals PLC [BDRX] share price is $4.40. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ARGX Stock Price Chart
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals PLC's stock price today?
-
The Biodexa Pharmaceuticals PLC share price today is $4.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.
ARGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.09 | Buy |
| Relative Strength Index (14 RSI): | 59.41 | Buy |
| Chaikin Money Flow: | 183983 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (560.06 - 595.04) | Buy |
| Bollinger Bands (100): | (487.11 - 568.53) | Buy |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 39.46 | Sell |
| Chaikin Money Flow: | -5027537 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.46 - 6.44) | Sell |
| Bollinger Bands (100): | (-0.1 - 4.74) | Buy |
ARGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 585.42 | Buy |
| 20-day SMA: | 581.79 | Buy |
| 50-day SMA: | 556.1 | Buy |
| 200-day SMA: | 456.98 | Buy |
| 8-day EMA: | 585.83 | Buy |
| 20-day EMA: | 579.35 | Buy |
| 50-day EMA: | 558.66 | Buy |
| 200-day EMA: | 488.51 | Buy |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.23 | Buy |
| 20-day SMA: | 5.23 | Sell |
| 50-day SMA: | 3.96 | Buy |
| 200-day SMA: | 1.73 | Buy |
| 8-day EMA: | 4.29 | Buy |
| 20-day EMA: | 4.75 | Sell |
| 50-day EMA: | 4.1 | Buy |
| 200-day EMA: | 12.21 | Sell |
argenx SE Earnings Growth & ARGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.74 per share, and an increase next year of $7.01 per share.
Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.
argenx SE Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals PLC Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||